Balanced news tone
News Sentiment
VKING sentiment intelligence
Viking Kagit ve Selüloz A.S. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
56
Balanced news tone
20 relevant articles
News tone and price action are not far from neutral.
90/100 classification confidence.
directly relevant articles
high-authority source matches
-1.2% over one week, +1.0% over four weeks, trend inactive, and below fair value.
VKTX Stock Has Nearly 300% Wall Street Upside — Is Viking’s Oral Obesity Pill The Next Novo Nordisk-Style Breakout?
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
90/100 classification
One-week reaction
-1.2%
Price digesting
Trend fit
Trend inactive
1.0% over four weeks
Fair value
-24.3%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
7
Neutral
12
Negative
1
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Stocktwits
Direct company coverage
VKTX Stock Has Nearly 300% Wall Street Upside — Is Viking’s Oral Obesity Pill The Next Novo Nordisk-Style Breakout?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 21 Jun 2026 08:45
- Source
- Stocktwits
Investor's Business Daily
Direct company coverage
Viking, Bloom Energy Lead Five Stocks Making Bullish Moves As Market Rebounds
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 Jun 2026 07:00
- Source
- Investor's Business Daily
The Motley Fool
Direct company coverage
Is Viking Therapeutics Stock Going to $100?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- The Motley Fool
The Motley Fool
Direct company coverage
Vail Resorts vs. Viking Cruises: Which Travel Stock Is a Better Buy in 2026?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 11 Jun 2026 07:00
- Source
- The Motley Fool
The Motley Fool
Direct company coverage
Why 1 Wall Street Analyst Thinks Viking Therapeutics Stock Could Soar 188%
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 10 Jun 2026 07:00
- Source
- The Motley Fool
The Motley Fool
Direct company coverage
5 Reasons Viking Is a Different Kind of Cruise Line Stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- The Motley Fool
The Motley Fool
Direct company coverage
Don't Buy Viking Therapeutics Stock Until You Read This
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 25 May 2026 07:00
- Source
- The Motley Fool
Investing.com
Direct company coverage
Viking Therapeutics: InvestingPro’s overvalued call proved prescient By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 May 2026 07:00
- Source
- Investing.com
Market source
Direct company coverage
Why Viking Therapeutics (VKTX) Is Down 8.4% After Expanding VK2735 Phase 3 Obesity Program And Loss
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 02 May 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Assessing Viking Therapeutics (VKTX) Valuation As Obesity Trial Optimism Meets Richer Balance Sheet Ratios
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Strength Seen in Viking (VIK): Can Its 6.8% Jump Turn into More Strength?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Better Long-Term Buy: Eli Lilly or Viking Therapeutics?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 17 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Is Viking Therapeutics the Ultimate Millionaire-Maker Obesity Stock for 2026?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Apr 2026 07:00
- Source
- Market source
Investor's Business Daily
Direct company coverage
Stock Of The Day Viking Outpaces Rivals, Near Buy Point
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Apr 2026 07:00
- Source
- Investor's Business Daily
The Motley Fool
Direct company coverage
Why Viking Therapeutics Stock Could Take Off Later This Year
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Mar 2026 07:00
- Source
- The Motley Fool
Investor's Business Daily
Direct company coverage
Viking Therapeutics Stock Gets RS Rating Upgrade
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 10 Mar 2026 07:00
- Source
- Investor's Business Daily
Market source
Direct company coverage
Why Viking Therapeutics Stock Is Up More Than 9% Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Feb 2026 08:00
- Source
- Market source
Market source
Direct company coverage
Is Viking Therapeutics Stock Really Going to $125?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Feb 2026 08:00
- Source
- Market source
Market source
Direct company coverage
Viking Therapeutics to Report Q4 Earnings: Here's What to Know
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 Jan 2026 08:00
- Source
- Market source
Market source
Direct company coverage
Viking Therapeutics (VKTX) Valuation Check After Recent Share Price Weakness
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jan 2026 08:00
- Source
- Market source